unilabs.com Our Company Areas of Expertise Our Network Investors People News & Media 12345 News 8/26/2015 Unilabs Reports Second Quarter 2015 Financial Results Unilabs announced further growth today, reporting that for the quarter ending 30 June 2015, revenue was €172.1m, compared to €153.5m in Q2 2014. The results show a significant and positive organic sales growth of 7.1% (CER†) leading to EBITDA growth vs Q2 2014 of 25.6%. This marks the 4th successive quarter of revenue growth, EBITDA growth and cost savings. More info in the News section 6/1/2015 Unilabs Sweden confirms its status as Mammography Market Leader with renewal of the Skåne Contract Unilabs has been fully responsible for women mammography screening for the region of Skane since 2009 and gets to renew the confidence of the Skåne region for another 5+2 years. The contract, that will start in April 2016, represents over €10.5M. More info in the News section Our Partnerships, Expertise & Network A Leader in Outsourcing We are a partner of choice and leading provider of outsourced diagnostic services with more than 200 diagnostic contracts across Europe. Most Comprehensive Diagnostics Portfolio Our services include: laboratory medicine, medical imaging, histopathology, reproductive medicine, and drug development services. Broadest Geographic Coverage With operations in 11 countries, we are positioned as a regional leader with one of the broadest geographic coverage in Europe. Laboratory Medicine Medical Imaging Cellular Pathology Reproductive Medicine Drug Development Services Scientific Leadership Find us © UNILABS 2012 OUR COMPANY History Our Commitment Board of Directors Executive Management Team Diagnostics Market Diagnostics Market Leader Unilabs at a Glance A Leader in Outsourcing AREAS OF EXPERTISE Laboratory Medicine Medical Imaging Histopathology Reproductive Medicine Drug Development Services Scientific Leadership OUR NETWORK Locations Headquarters INVESTORS Investor Relations PEOPLE People HR Philosophy Careers NEWS Media & News